1. Home
  2. Labeler Index
  3. Nivagen Pharmaceuticals, Inc.
  4. 75834-101
  5. Label Information: Psoriatar (coal Tar)

FDA Label for Psoriatar (coal Tar)

View Indications, Usage & Precautions

Table of Contents

    1. OTHER
    2. ACTIVE INGREDIENT
    3. PURPOSE
    4. USE
    5. WARNINGS
    6. FLAMMABLE
    7. DO NOT USE
    8. OTC - ASK DOCTOR
    9. OTC - ASK DOCTOR/PHARMACIST
    10. OTC - WHEN USING
    11. OTC - STOP USE
    12. OTC - PREGNANCY OR BREAST FEEDING
    13. OTC - KEEP OUT OF REACH OF CHILDREN
    14. DIRECTIONS
    15. OTHER INFORMATION
    16. INACTIVE INGREDIENTS
    17. QUESTIONS?
    18. PRINCIPAL DISPLAY PANEL - 100 G CAN LABEL

Psoriatar (coal Tar) Product Label

The following document was submitted to the FDA by the labeler of this product Nivagen Pharmaceuticals, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Other



Drug Facts


Active Ingredient



Coal Tar 2% (from Coal Tar Topical Solution USP, 10%)


Purpose



Psoriasis


Use



for the relief of symptons of psoriasis


Warnings



For external use only


Flammable



Avoid fire, flame, or smoking during and immediately following application.


Do Not Use



  • for prolonged periods without consulting a doctor
  • this product in or around the rectum or in the genital area or groin except on the advice of a doctor

Otc - Ask Doctor



Ask a doctor before use if you have a condition that covers large areas of the body.


Otc - Ask Doctor/Pharmacist



Ask a doctor or pharmacist before use if you are using the product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.


Otc - When Using



When using this product

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
  • use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.
  • Product can stain clothing, contact lenses and hair. To minimize staining, allow product to dry before contact.

Otc - Stop Use



Stop use and ask doctor if condition worsens or does not improve after regular use of this product as directed.


Otc - Pregnancy Or Breast Feeding



If pregnant or breast feeding, ask a health professional before use.


Otc - Keep Out Of Reach Of Children



Keep out of reach of children.

If swallowed, get medical help or contact a poison control center right away.


Directions



  • Shake the can before use.
  • Invert the can to dispense. Upright dispensing will cause loss of propellant.
  • Apply to affected areas one to four times daily or as directed by a doctor.

Other Information



  • Contents under pressure. Do not puncture or incinerate.
  • Store at 68°-77°F (20°-25°C).
  • Do not expose to heat or at temperatures above 120°F (49°C).

Inactive Ingredients



Alcohol denatured, caprylic/capric triglyceride, ceteareth-20, cyclopentasiloxane, dimethicone, disodium edta, glycerin, hydroxypropyl methylcellulose, isobutane, isopropyl myristate, mentha piperita (peppermint) oil, phenoxyethanol, polysorbate 80, potassium sorbate, propane, sodium chloride, sodium citrate, stearic acid, water (aqua), xantham gum


Questions?



1-877-977-0687


Principal Display Panel - 100 G Can Label



75834-101-01
PSORIASIS FOAM

Psoriatar™

(Coal Tar) Foam 2%

NIVAGEN
PHARMACEUTICALS

Net wt. 3.5 oz (100 g)

PRINCIPAL DISPLAY PANEL - 100 g Can Label - psoriatar 01

PRINCIPAL DISPLAY PANEL - 100 g Can Label - psoriatar 01


* Please review the disclaimer below.